esmolol ^Turanci (Q418139)

Daga Wikidata

Jump to navigation Jump to search

chemical compound ^Turanci

Language	Label	Description	Also known as
Hausa	Ba suna a kai	Ba'a bayyana ma'ana ba
Turanci	esmolol	chemical compound	Brevibloc® SL-8052 (±)-esmolol (±)-methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate 3-[4-(2-Hydroxy-3-isopropylamino-propoxy)-phenyl]-propionic acid methyl ester Methyl 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoate methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Esmolol

Statements

type of chemical entity ^Turanci

0 references

Ƙaramin ɓangare na

chemical compound ^Turanci

0 references

0 references

tsarin sinadaran

Esmolol Structure.svg
504 × 203; 13 KB

0 references

295.178 dalton

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

sinadaran dabara

C₁₆H₂₅NO₄

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

canonical SMILES ^Turanci

CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

defined daily dose ^Turanci

2.5 gram

route of administration ^Turanci

parenteral route of administration ^Turanci

1 reference

adireshin manazarta

https://www.whocc.no/atc_ddd_index/?code=C07AB09

active ingredient in ^Turanci

Brevibloc ^Turanci

1 reference

stated in ^Turanci

RxNorm ^Turanci

RxNorm ID ^Turanci

retrieved ^Turanci

14 Faburairu 2018

World Health Organisation international non-proprietary name ^Turanci

Esmolol (Turanci)

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

harshen aiki ko suna

Esmolol (Turanci)

retrieved ^Turanci

19 Janairu 2016

medical condition treated ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

congestive heart failure ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

angina pectoris ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

supraventricular tachycardia ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

ventricular fibrillation ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

13 Disamba 2016

significant drug interaction ^Turanci

verapamil ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

digoxin ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

crizotinib ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

verapamil ^Turanci

matsalar da zata iya haifarwa

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clonidine ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

rivastigmine ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

matsalar da zata iya haifarwa

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

clonidine ^Turanci

matsalar da zata iya haifarwa

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

diltiazem ^Turanci

matsalar da zata iya haifarwa

myocardial depression ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

matsalar da zata iya haifarwa

sinoatrial arrest ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

matsalar da zata iya haifarwa

atrioventricular block ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

amiodarone ^Turanci

matsalar da zata iya haifarwa

hypotension ^Turanci

1 reference

sourcing circumstances ^Turanci

established ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

digoxin ^Turanci

matsalar da zata iya haifarwa

toxicity ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

dronedarone ^Turanci

matsalar da zata iya haifarwa

sinus bradycardia ^Turanci

1 reference

sourcing circumstances ^Turanci

probably ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

matsalar da zata iya haifarwa

decreased heart rate ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

matsalar da zata iya haifarwa

shortened atrioventricular conduction time ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

fingolimod ^Turanci

matsalar da zata iya haifarwa

atrioventricular block ^Turanci

1 reference

sourcing circumstances ^Turanci

hypothetically ^Turanci

stated in ^Turanci

A reference set of clinically relevant adverse drug-drug interactions ^Turanci

ta jiki ma'amala da

Adrenoceptor beta 1 ^Turanci

subject has role ^Turanci

antagonist ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

harshen aiki ko suna

retrieved ^Turanci

17 Agusta 2016

pregnancy category ^Turanci

Australian pregnancy category C ^Turanci

1 reference

English Wikipedia ^Turanci

US pregnancy category C ^Turanci

1 reference

English Wikipedia ^Turanci

subject has role ^Turanci

beta blocker ^Turanci

1 reference

stated in ^Turanci

NDF-RT ^Turanci

NDF-RT ID ^Turanci

retrieved ^Turanci

5 Maris 2018

Adrenergic beta-1 Receptor Antagonists ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

15 Maris 2018

Commons category ^Turanci

Esmolol

0 references

Identifiers

InChI ^Turanci

InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

AQNDDEOPVVGCPG-UHFFFAOYSA-N

2 references

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

stated in ^Turanci

ChEBI release 2020-09-01 ^Turanci

CAS Registry Number ^Turanci

2 references

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

InChIKey ^Turanci

AQNDDEOPVVGCPG-UHFFFAOYSA-N

stated in ^Turanci

CAS Common Chemistry ^Turanci

retrieved ^Turanci

8 Afirilu 2021

adireshin manazarta

https://commonchemistry.cas.org/detail?cas_rn=81147-92-4

ChemSpider ID ^Turanci

1 reference

stated in ^Turanci

ChemSpider ^Turanci

ChemSpider ID ^Turanci

harshen aiki ko suna

Esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

PubChem CID ^Turanci

1 reference

stated in ^Turanci

PubChem ^Turanci

PubChem CID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

Reaxys registry number ^Turanci

5287174

0 references

ChEBI ID ^Turanci

mapping relation type ^Turanci

exact match ^Turanci

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

ChEMBL ID ^Turanci

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

harshen aiki ko suna

ESMOLOL (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

SureChEMBL ID ^Turanci

1 reference

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

UniChem compound ID ^Turanci

1 reference

stated in ^Turanci

UniChem ^Turanci

MassBank accession ID ^Turanci

MSBNK-Waters-WA001932

0 references

MSBNK-Waters-WA001933

0 references

MSBNK-Waters-WA001934

0 references

MSBNK-Waters-WA001935

0 references

MSBNK-Waters-WA001936

0 references

DSSTox substance ID ^Turanci

1 reference

stated in ^Turanci

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^Turanci

DSSTOX compound identifier ^Turanci

0 references

LiverTox ID ^Turanci

0 references

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Esmolol (Turanci)

17 Nuwamba 2015

Guide to Pharmacology Ligand ID ^Turanci

1 reference

stated in ^Turanci

IUPHAR/BPS Guide to PHARMACOLOGY ^Turanci

Guide to Pharmacology Ligand ID ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

MeSH descriptor ID ^Turanci

1 reference

stated in ^Turanci

Medical Subject Headings ^Turanci

MeSH descriptor ID ^Turanci

retrieved ^Turanci

14 Maris 2018

RxNorm ID ^Turanci

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

DrugBank ID ^Turanci

1 reference

stated in ^Turanci

DrugBank ^Turanci

DrugBank ID ^Turanci

harshen aiki ko suna

Esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

Human Metabolome Database ID ^Turanci

1 reference

based on heuristic ^Turanci

inferred from InChIKey ^Turanci

UNII ^Turanci

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

NDF-RT ID ^Turanci

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

Probes And Drugs ID ^Turanci

0 references

DrugCentral ID ^Turanci

1 reference

stated in ^Turanci

UniChem ^Turanci

KEGG ID ^Turanci

1 reference

stated in ^Turanci

ChEMBL ^Turanci

ChEMBL ID ^Turanci

harshen aiki ko suna

Esmolol (Turanci)

retrieved ^Turanci

19 Janairu 2016

Freebase ID ^Turanci

1 reference

stated in ^Turanci

Freebase Data Dumps ^Turanci

28 Oktoba 2013

Microsoft Academic ID ^Turanci

0 references

OpenAlex ID ^Turanci

1 reference

stated in ^Turanci

OpenAlex ^Turanci

retrieved ^Turanci

26 Janairu 2022

adireshin manazarta

https://docs.openalex.org/download-snapshot/snapshot-data-format

UMLS CUI ^Turanci

1 reference

stated in ^Turanci

Global Substance Registration System ^Turanci

UNII ^Turanci

harshen aiki ko suna

esmolol (Turanci)

retrieved ^Turanci

18 Nuwamba 2016

1 reference

based on heuristic ^Turanci

inferred by common MeSH mappings on source and on Wikidata ^Turanci

stated in ^Turanci

UMLS 2023 ^Turanci

retrieved ^Turanci

25 Mayu 2023

WikiProjectMed ID ^Turanci

0 references

WordNet 3.1 Synset ID ^Turanci

03301688-n

1 reference

stated in ^Turanci

GF WordNet ^Turanci

Sitelinks

Wikipedia(21 entries)

arwiki إسمولول
azbwiki اسمولول
bswiki Esmolol
cywiki Esmolol
dewiki Esmolol
enwiki Esmolol
eswiki Esmolol
fawiki اسمولول
frwiki Esmolol
hewiki אסמולול
huwiki Ezmolol
itwiki Esmololo
kowiki 에스모롤
orwiki ଏସମୋଲୋଲ
plwiki Esmolol
ptwiki Esmolol
rowiki Esmolol
shwiki Esmolol
srwiki Esmolol
ukwiki Есмолол
viwiki Esmolol

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Wasu shafuka(1 entry)

commonswiki Category:Esmolol

Daga "https://www.wikidata.org/w/index.php?title=Q418139&oldid=2146877982"